These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 2643213)
1. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Inaba S; Sato H; Okochi K; Fukada K; Takakura F; Tokunaga K; Kiyokawa H; Maeda Y Transfusion; 1989 Jan; 29(1):7-11. PubMed ID: 2643213 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Inaba S; Okochi K; Sato H; Fukada K; Kinukawa N; Nakata H; Kinjyo K; Fujii F; Maeda Y Transfusion; 1999 Oct; 39(10):1104-10. PubMed ID: 10532605 [TBL] [Abstract][Full Text] [Related]
3. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors. Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334 [TBL] [Abstract][Full Text] [Related]
4. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Manns A; Wilks RJ; Murphy EL; Haynes G; Figueroa JP; Barnett M; Hanchard B; Blattner WA Int J Cancer; 1992 Jul; 51(6):886-91. PubMed ID: 1639536 [TBL] [Abstract][Full Text] [Related]
5. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
6. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805 [TBL] [Abstract][Full Text] [Related]
7. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors. Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675 [TBL] [Abstract][Full Text] [Related]
8. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329 [TBL] [Abstract][Full Text] [Related]
9. Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: higher positivity rates by particle agglutination assay [corrected]. Ishizaki J; Okayama A; Tachibana N; Yokota T; Shishime E; Tsuda K; Mueller N J Acquir Immune Defic Syndr (1988); 1988; 1(4):340-5. PubMed ID: 3063808 [TBL] [Abstract][Full Text] [Related]
10. Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Kleinman S; Swanson P; Allain JP; Lee H Transfusion; 1993 Jan; 33(1):14-8. PubMed ID: 8424263 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867 [TBL] [Abstract][Full Text] [Related]
12. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Donegan E; Lee H; Operskalski EA; Shaw GM; Kleinman SH; Busch MP; Stevens CE; Schiff ER; Nowicki MJ; Hollingsworth CG Transfusion; 1994 Jun; 34(6):478-83. PubMed ID: 8023388 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal. Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan. Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641 [TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance. Urwijitaroon Y; Barusrux S; Puapairoj C; Romphruk A; Khampeera P J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S102-5. PubMed ID: 9347655 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
19. [Pretransfusion screening tests for HIV and HTLV-I in donated blood]. Okubo S Rinsho Byori; 1989 Jul; 37(7):762-7. PubMed ID: 2607646 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Karimi G; Zadsar M; Pourfathollah AA Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]